Product news

Share this article:
Mylan received FDA approval for generic versions of AstraZeneca's hypertension treament, Plendil extended-release tablets. Mylan said it received approval for 2.5 mg, 5 mg, and 10 mg doses and already started shipping the product.

Pfizer received approval to market its anti-tumor drug/kinase inhibitor Sutent capsule 12.5 mg (sunitinib malate) in Japan. Sutent is indicated for gastrointestinal stromal tumor after failure of imatinib treatment due to resistance and for renal cell carcinoma not indicated for curative resection and metastatic renal cell carcinoma. Sutent was approved in the US in January 2006.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

AstraZeneca takes on pediatricians

The American Academy of Pediatricians says an AstraZeneca drug for preemies should be used less often, and the drugmaker is fighting back with an ad campaign that says the new guidelines put too many at risk.

UK generic use soared in 2013

Generics made up almost 75% of prescriptions in the United Kingdom last year.

GSK refutes consumer spin-off rumor

The company refutes a Financial Times rumor that one was happening soonish.